Since the overexpression of EGFR and PHD2 in a hypoxic environment may have a profound role in breast tumor progression and metastases [4, 23–25], we hypothesized that there might be an association on a molecular level between PHD2 and EGFR. This evidence concerns the gene EGLN1 and breast neoplasm.